-
Merck’s Keytruda gets FDA approval to treat kidney cancer
pharmaceutical-technology
April 24, 2019
Merck has received US Food and Drug Administration (FDA) approval for its anti-PD-1 therapy Keytruda to treat advanced renal cell carcinoma (RCC) patients.
-
MDxHealth's SelectMDx Test Successfully Stratifies Men Who May Benefit from mp-MRI for Prostate Cancer Diagnosis
b3cnewswire
April 23, 2019
MDxHealth's SelectMDx Test Successfully Stratifies Men Who May Benefit from mp-MRI for Prostate Cancer Diagnosis.
-
Puma licences breast cancer therapy to Pierre Fabre in Europe
pharmaceutical-technology
April 23, 2019
Puma licences breast cancer therapy to Pierre Fabre in Europe.
-
AstraZeneca’s Lynparza gets EC approval for breast cancer
pharmaceutical-technology
April 23, 2019
The European Commission (EC) has approved AstraZeneca drug Lynparza (olaparib) as a monotherapy to treat locally-advanced or metastatic breast cancer in adults.
-
Repurposing cancer drugs may lead to a new approach to treating TB
europeanpharmaceuticalreview
April 22, 2019
Promising experimental cancer chemotherapy drugs may help knock out another life-threatening disease: tuberculosis (TB)…
-
Moleculin Announces Significant Discovery in Lung Cancer Models
americanpharmaceuticalreview
April 22, 2019
Moleculin Announces Significant Discovery in Lung Cancer Models...
-
Janssen’s bladder cancer drug Balversa receives FDA nod
pharmaceutical-technology
April 22, 2019
Janssen Pharmaceutical has received the US Food and Drug Administration (FDA) approval for the drug Balversa (erdafitinib) to treat adults with locally advanced or metastatic urothelial carcinoma (mUC).
-
Developing a new radioactive marker for cancer diagnosis and detection
europeanpharmaceuticalreview
April 22, 2019
Scientists are conducting a joint study to develop a radioactive marker, based on nanoparticles, for the detection of cancer…
-
Saliva diagnostics: Will saliva translate into a real diagnostic tool?
europeanpharmaceuticalreview
April 22, 2019
Saliva has been used to measure stress hormones, enzyme levels and cancer mutations…
-
Blood test can detect early stage pancreatic cancer
europeanpharmaceuticalreview
April 22, 2019
A blood test has been developed to detect pancreatic cancer at its earliest stages with an accuracy rate of 96 percent…